Sec Form 13G Filing - John Simard filing for - 2026-01-23

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  (1) This amount includes (i) 3,823,166 shares of common stock held by the Reporting Person, (ii) 1,896,609 shares of common stock issuable upon the exercise of stock options that are immediately exercisable within 60 days of December 31, 2025 held by the Reporting Person. (2) The percentage is calculated based upon a denominator that includes (i) 30,487,731 shares outstanding as of December 31, 2025 and (ii) 1,896,609 shares that are issuable upon the exercise of stock options by the Reporting Person.


SCHEDULE 13G


 
John Simard
 
Signature:/s/ John Simard
Name/Title:John Simard/Chairman of the Board of Directors, XBiotech Inc.
Date:01/23/2026
primary_doc.xml